Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

301.21 -3.48 (-1.14%)
Streaming Delayed Price Updated: 2:02 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 216,469
Open 305.85
Bid (Size) 300.74 (2)
Ask (Size) 301.25 (1)
Prev. Close 304.69
Today's Range 298.00 - 307.35
52wk Range 289.01 - 459.77
Shares Outstanding 30,998,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Market-Beating Stocks with Solid Fundamentals
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the... 
Via StockStory
1 Healthcare Stock with Solid Fundamentals and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities

Performance

YTD
-10.0%
-10.0%
1 Month
-5.6%
-5.6%
3 Month
-9.6%
-9.6%
6 Month
-9.8%
-9.8%
1 Year
-24.3%
-24.3%

More News

Read More
This Kraft Heinz Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
Via StockStory
Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025
From Medpace Holdings, Inc.
Via Business Wire
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)
Via StockStory
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Via StockStory
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
Via StockStory
2 Reasons to Watch MEDP and 1 to Stay Cautious
Via StockStory
Topics Stocks
Exposures US Equities
Why Medpace (MEDP) Shares Are Trading Lower Today
Via StockStory
Harmonic Issues Weak Guidance, Joins Fluence Energy, Amkor Technology And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
Via Chartmill
Medpace Stock Falls On Q4 Earnings: The Details
Via Benzinga
Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops
Via StockStory
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results
From Medpace Holdings, Inc.
Via Business Wire
Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025
From Medpace Holdings, Inc.
Via Business Wire
Earnings Scheduled For February 10, 2025
Via Benzinga
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm
Via ACCESSWIRE
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations
Via ACCESSWIRE
Medpace Holdings, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
Via ACCESSWIRE
The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medpace Holdings Inc For Securities Law Violations
Via ACCESSWIRE
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm
Via ACCESSWIRE
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is Medpace Holdings, Inc. - Common Stock publicly traded?
Yes, Medpace Holdings, Inc. - Common Stock is publicly traded.
What exchange does Medpace Holdings, Inc. - Common Stock trade on?
Medpace Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medpace Holdings, Inc. - Common Stock?
The ticker symbol for Medpace Holdings, Inc. - Common Stock is MEDP on the Nasdaq Stock Market
What is the current price of Medpace Holdings, Inc. - Common Stock?
The current price of Medpace Holdings, Inc. - Common Stock is 301.21
When was Medpace Holdings, Inc. - Common Stock last traded?
The last trade of Medpace Holdings, Inc. - Common Stock was at 04/01/25 02:02 PM ET
What is the market capitalization of Medpace Holdings, Inc. - Common Stock?
The market capitalization of Medpace Holdings, Inc. - Common Stock is 9.34B
How many shares of Medpace Holdings, Inc. - Common Stock are outstanding?
Medpace Holdings, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.